David Goldblatt

Active 1971–2025

129
Papers
20,688
Citations
77
h-index
125
i10-index

Citations

Citations per year for David Goldblatt1947: 2 citations1976: 1 citations1981: 3 citations1983: 4 citations1986: 3 citations1988: 1 citations1990: 3 citations1991: 4 citations1992: 4 citations1993: 1 citations1994: 3 citations1995: 5 citations1996: 4 citations1997: 3 citations1998: 3 citations1999: 11 citations2000: 31 citations2001: 53 citations2002: 35 citations2003: 67 citations2004: 68 citations2005: 75 citations2006: 100 citations2007: 88 citations2008: 104 citations2009: 116 citations2010: 104 citations2011: 72 citations2012: 72 citations2013: 84 citations2014: 99 citations2015: 98 citations2016: 96 citations2017: 118 citations2018: 75 citations2019: 303 citations2020: 311 citations2021: 591 citations2022: 491 citations2023: 316 citations2024: 437 citations2025: 148 citations2026: 4 citations1948–1975: no citations, so these years are not shown1977–1980: no citations, so these years are not shown1982: no citations, so this year is not shown1984–1985: no citations, so these years are not shown1987: no citations, so this year is not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,392 citing papers, 21.1% of this breakdownUnited Kingdom: 931 citing papers, 14.1% of this breakdownAustralia: 317 citing papers, 4.8% of this breakdownGermany: 291 citing papers, 4.4% of this breakdownCanada: 270 citing papers, 4.1% of this breakdownNetherlands: 226 citing papers, 3.4% of this breakdownItaly: 213 citing papers, 3.2% of this breakdownFrance: 208 citing papers, 3.2% of this breakdownSwitzerland: 160 citing papers, 2.4% of this breakdownChina: 160 citing papers, 2.4% of this breakdownSouth Africa: 136 citing papers, 2.1% of this breakdownBelgium: 122 citing papers, 1.9% of this breakdown
0%21.1%Other 32.9%

Fields

  • Medicine61.6%
  • Immunology and Microbiology17.8%
  • Biochemistry, Genetics and Molecular Biology7.3%
  • Social Sciences5%
  • Neuroscience2.3%
  • Nursing1%
  • Other5%

Topics

  • Pneumonia and Respiratory Infections9%
  • SARS-CoV-2 and COVID-19 Research7.5%
  • Respiratory viral infections research5.7%
  • Bacterial Infections and Vaccines4.6%
  • COVID-19 Clinical Research Studies4%
  • Heparin-Induced Thrombocytopenia and Thrombosis3%
  • Other66.2%

Coauthors

All papers

Open in search
  1. Correlates of protection against SARS‐CoV‐2 infection and COVID‐19 disease

    Authors: , , , - Immunological Reviews 2022 cited by 323

  2. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hakam Abbass, Aderonke Abiodun, Mashael Alfarih, Zoe Alldis, Mervyn Andiapen, Jessica Artico, João B. Augusto, Georgina L. Baca, Sasha N. L. Bailey, Anish Bhuva, Alex Boulter, Ruth Bowles, Rosemary J. Boyton, Olivia V. Bracken, Benjamin O’Brien, Tim Brooks, Natalie Bullock, David K. Butler, Gabriella Captur, Nicola Champion, Carmen K. M. Chan, David Collier, Jorge Couto de Sousa, Xosé Couto‐Parada, Teresa Cutino-Mogue, Rhodri Davies, Brooke Douglas, Cecilia Di Genova, Keenan Dieobi-Anene, Anaya Ellis, Karen Feehan, Malcolm Finlay, Marianna Fontana, Nasim Forooghi, Celia Gaier, Derek W. Gilroy, Matt Hamblin, Gabrielle Harker, Jacqueline Hewson, Lauren M. Hickling, Aroon D. Hingorani, Lee Hamill Howes, Alun D. Hughes, Gemma Hughes, Rebecca Hughes, Ivie Itua, Victor Jardim, Wing-Yiu Jason Lee, Melanie Jensen, Jessica Jones, Meleri Jones, George Joy, Vikas Kapil, Hibba Kurdi, Jonathan Lambourne, Kai‐Min Lin, Sarah Louth, Vineela Mandadapu, Áine McKnight, Katia Menacho, Celina Mfuko, Oliver Mitchelmore, Christopher Moon, Diana Mūnoz Sandoval, Sam M. Murray, Mahdad Noursadeghi, Ashley Otter, Susana Palma, Ruth Parker, Kush Patel and 34 more - Nature 2021 cited by 426

  3. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study

    Authors: , , , , , , , , , - The Lancet Infectious Diseases 2014 cited by 545

  4. Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

    Authors: , , , , , , , , , - New England Journal of Medicine 2021 cited by 995

  5. Dense genomic sampling identifies highways of pneumococcal recombination

    Authors: , , , , , , , , , , , , , , , , , - Nature Genetics 2014 cited by 410

  6. When to update COVID-19 vaccine composition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 51

  7. Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2

    Authors: , , , , , , , - Nature Immunology 2022 cited by 56

  8. Towards a population-based threshold of protection for COVID-19 vaccines

    Authors: , , , , , , , , , , , , , , , - Vaccine 2021 cited by 183

  9. Waning of antibody levels induced by a 13-valent pneumococcal conjugate vaccine, using a 3 + 0 schedule, within the first year of life among children younger than 5 years in Blantyre, Malawi: an observational, population-level, serosurveillance study

    Authors: , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2022 cited by 61

  10. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

    Authors: , , , , , , , , , , , - Vaccine 2003 cited by 387

  11. Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew J. Ahearne, Peter Johnson, Andrew Davies, David Goldblatt - Nature Cancer 2022 cited by 90

  12. Hybrid immunity expands the functional humoral footprint of both mRNA and vector-based SARS-CoV-2 vaccines

    Authors: , , , , , , , , - Cell Reports Medicine 2023 cited by 33

  13. Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration

    Authors: , , , , , , , - eLife 2017 cited by 119

  14. Comprehensive Identification of Single Nucleotide Polymorphisms Associated with Beta-lactam Resistance within Pneumococcal Mosaic Genes

    Authors: , , , , , , , , , , , , - PLoS Genetics 2014 cited by 248

  15. A Longitudinal Study of Streptococcus pneumoniae Carriage in a Cohort of Infants and Their Mothers on the Thailand-Myanmar Border

    Authors: , , , , , , , , - PLoS ONE 2012 cited by 160

  16. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

    Authors: , , , , , , , , , , , - The Lancet Infectious Diseases 2017 cited by 134

  17. An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model

    Authors: , , , , , , , , , , , , - mBio 2019 cited by 87

  18. Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

    Authors: , , , , , , , , , , , , , , , - npj Vaccines 2024 cited by 29

  19. Enzyme-Linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides

    Authors: , , , , , , , , , , , , - Clinical and Vaccine Immunology 2003 cited by 337

  20. Use of Opsonophagocytosis for Serological Evaluation of Pneumococcal Vaccines

    Authors: , , , , , - Clinical and Vaccine Immunology 2006 cited by 214

  21. Controlled Human Infection and Rechallenge with Streptococcus pneumoniae Reveals the Protective Efficacy of Carriage in Healthy Adults

    Authors: , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2013 cited by 196

  22. Cutaneous and other lupus-like symptoms in carriers of X-linked chronic granulomatous disease: incidence and autoimmune serology

    Authors: , , - Clinical & Experimental Immunology 2007 cited by 157

  23. Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies

    Authors: , , , , , , , , , , , - mBio 2020 cited by 58

  24. The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations

    Authors: , , , , , , , , , , , , - Vaccine 2019 cited by 57